Home/Bitterroot Bio/Irving L. Weissman, MD

IL

Irving L. Weissman, MD

Co-Founder, Professor of Pathology at Stanford, Board Director

Therapeutic Areas

Cardiovascular Disease Atherosclerosis

Bitterroot Bio Pipeline

Drug	Indication	Phase
Anti-CD47 Therapy	Atherosclerosis / Prevention of Major Adverse Cardiovascular Events (MACE)	Pre-clinical

Leadership Team at Bitterroot Bio

Interim CEO & Board Director

Nick Leeper, MD

Co-Founder, Chief of Vascular Medicine at Stanford, Board Director

Steve Gillis, PhD

Managing Director, ARCH Venture Partners; Executive Chairman of the Board

View full Bitterroot Bio profile